Results 91 to 100 of about 742 (141)

[Corticotropin-producing pheochromocytoma in multiple endocrine neoplasia type 1]. [PDF]

Probl Endokrinol (Mosk), 2023
Rebrova DV, Grigorova SI, Vorokhobina NV, Zgoda EA, Novokshonov KY, Feofanova SG, Rusakov VF, Krasnov LM, Fedorov EA, Chinchuk IK, Shikhmagomedov SS, Pushkaruk AA, Sleptsov IV.   +12 more
europepmc   +1 more source

Хроническая болезнь почек: недооцененные факторы риска и новые клинические рекомендации

Traditional and new risk factors of chronic kidney disease are discussed. The importance of risk factors for chronic kidney disease in Russian clinical guidelines 2021 was demonstrated.Обсуждаются традиционные и новые факторы риска хронической болезни ...
Фомин В.В., Котенко О.Н.
core  

[The impact of BMI on the course of the acute SARS-COV-2 infection and the risks that emerge during the first year after the hospital discharge. Subanalysis evidence of the AKTIV and AKTIV 2 registries]. [PDF]

Probl Endokrinol (Mosk), 2023
Arutyunov AG, Tarlovskaya EI, Galstyan GR, Batluk TI, Bashkinov RA, Arutyunov GG, Belenkov YN, Konradi AO, Lopatin YM, Rebrov AP, Tereshchenko SN, Chesnikova AI, Hayrapetyan HG, Babin AP, Bakulin IG, Bakulina NV, Balykova LA, Blagonravova AS, Boldina MV, Butomo MI, Vaisberg AR, Galyavich AS, Gomonova VV, Grigoryeva NY, Gubareva IV, Demko IV, Evzerikhina AV, Zharkov AV, Zateishchikova AA, Kamilova UK, Kim ZF, Kuznetsova TY, Kulikov AN, Lareva NAV, Makarova EV, Malchikova SV, Nedogoda SV, Petrova MM, Pochinka IG, Protasov KV, Protsenko DN, Ruzanov DY, Saiganov SA, Sarybaev AS, Selezneva NM, Sugraliev AB, Fomin IV, Khlynova OV, Chizhova OY, Shaposhnik II, Schukarev DA, Abdrakhmanova AK, Avetisyan SA, Avoyan HG, Azaryan KK, Aimakhanova GT, Ayypova DA, Akunov AC, Alieva MK, Almukhambedova AR, Aparkina AV, Aruslanova OR, Ashina EY, Badina ONY, Barysheva OY, Batchaeva AS, Bitieva AM, Bikhteev IU, Borodulina NA, Bragin MV, Brazhnik VA, Budu AM, Bykova GA, Vagapova KR, Varlamova DD, Vezikova NN, Verbitskaya EA, Vilkova OE, Vinnikova EA, Vustina VV, Galova EA, Genkel VV, Giller DB, Gorshenina EI, Grigoryeva EV, Gubareva EY, Dabylova GM, Demchenko AI, Dolgikh OY, Duishobaev MY, Evdokimov DS, Egorova KE, Ermilova AN, Zheldybaeva AE, Zarechnova NV, Zimina YD, Ivanova SY, Ivanchenko EY, Ilina MV, Kazakovtseva MV, Kazymova EV, Kalinina YS, Kamardina NA, Karachenova AM, Karetnikov IA, Karoli NA, Karsiev MK, Kaskaeva DS, Kasymova KF, Kerimbekova ZB, Kim ES, Kiseleva NV, Klimenko DA, Klimova AV, Kovalishena OV, Kozlov SV, Kolmakova EV, Kolchinskaya TP, Kolyadich MI, Kondryakova OV, Konoval MP, Konstantinov DY, Konstantinova EA, Kordyukova VA, Koroleva EV, Kraposhina AY, Kryukova TV, Kuznetsova AS, Kuzmina TY, Kuzmichev KV, Kulchoroeva CK, Kuprina TV, Kuranova IAM, Kurenkova LVV, Kurchugina NY, Kushubakova NA, Levankova VI, Ledyaeva AA, Lisun TV, Lisyanskaya VE, Lyubavina NA, Magdeeva NA, Mazalov KV, Mayseenko VI, Makarova AS, Maripov AM, Markov NV, Marusina AA, Melnikov ES, Metlinskaya AI, Moiseenko NB, Muradova FN, Muradyan RG, Musaelyan SN, Nekaeva ES, Nikitina NM, Nifontov SE, Obolentseva EY, Obukhova AA, Ogurlieva BB, Odegova AA, Omarova YV, Omurzakova NA, Ospanova SO, Pavlova VA, Pakhomova EVP, Petrov LD, Plastinina SS, Platonov DA, Pogrebetskaya VAA, Polyakov DV, Polyakov DS, Ponomarenko EEV, Popova LL, Potanin AA, Prokofieva NA, Rabik YD, Rakov NA, Rakhimov AN, Rozanova NA, Samus IV, Serikbolkyzy S, Sidorkina YA, Simonov AA, Skachkova VV, Skvortsova RD, Skuridin DS, Solovieva DV, Solovieva IA, Sukhomlinova IM, Sushilova AG, Tagaeva DR, Titoykina YV, Tikhonova EP, Tokmin DS, Tolmacheva AA, Torgunakova MS, Trenogina KV, Trostyanetskaya NAA, Trofimov DA, Trubnikova MA, Tulichev AA, Tursunova AT, Ulanova ND, Fatenkov OV, Fedorishina OV, Fil TS, Fomina IY, Fominova IS, Frolova IA, Tsvinger SM, Tsoma VV, Cholponbaeva MB, Chudinovskikh TSI, Shavrin IV, Shevchenko OA, Shikhaliev DR, Shishkina EA, Shishkov KY, Shcherbakov SY, Shcherbakova GV, Yausheva EA.   +221 more
europepmc   +1 more source

Фармакоэкономика хронической болезни почек

, 2018
A pharmacoeconomic study is a comprehensive scientific and research activity, which should take into account specific characteristics of a research subject as well as nosology based on common methodological approaches of pharmacoeconomics,.
V. G. Serpik, M. V. Protsenko, G. T. Abdrashitova, Р. И. Ягудина, М. В. Проценко, В. Г. Серпик, A. Yu. Kulikov, Г. Т. Абдрашитова, А. Ю. Куликов, R. I. Yagudina   +9 more
core  

Прогнозирование частоты развития хронической болезни почек после чрескожных вмешательств у пациентов с острым инфарктом миокарда и острым почечным повреждением

Атеросклероз, 2022
О. Демчук, И. Сукманова
doaj   +1 more source

[FGF23 tumor induced osteomalacia]. [PDF]

Probl Endokrinol (Mosk), 2022
Gronskaia SA, Belaya ZE, Melnichenko GA.
europepmc   +1 more source

EPIDEMIOLOGICAL MANIFESTATIONS OF PREVALENCE OF GLOMERULAR-TUBULOINTERSTITIAL DISEASES OF KIDNEYS AND URETER IN AREAS WITH DIFFERENT LEVELS OF ANTHROPOGENIC LOAD

Acta Biomedica Scientifica, 2014
The article reviews the features of the manifestations of the prevalence of glomerular-tubulointerstitial diseases of kidneys and ureter (GTIDKU) in Ufa, Salavat and Sterlitamak with severe anthropogenic load in comparison with the more prosperous ...
N. S. Karpina, V. I. Nikulicheva, G. E. Efimov, T. V. Kaydanek, G. M. Shaykhieva   +4 more
doaj  

[Pituitary and COVID-19: review]. [PDF]

Probl Endokrinol (Mosk), 2022
Buyvalenko UV, Perepelova MA, Zolotareva RA, Belaya ZE, Melnichenko GA.   +4 more
europepmc   +1 more source

Особенности динамики эндотелиальной дисфункции под влиянием терапии у больных хронической болезнью почек с артериальной гипертензией

, 2020
Исследуется проблема наиболее эффективных воздействий на эндотелиальную дисфункцию при хронической болезни почек с артериальной гипертензией. Сравнивается эффективность лизиноприла с кандесартаном в отношении динамики фактора Вилллибранда и S ...
Шелест, Б. А., Полищук, В. Т., Костюк, И. Ф., Капустник, В. А.   +3 more
core  

The global burden of kidney disease and the sustainable development goals. [PDF]

Bull World Health Organ, 2018
Luyckx VA, Tonelli M, Stanifer JW.
europepmc   +1 more source